Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot Q04637 (IF4G1_HUMAN)

Last modified November 25, 2008. Version 96. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Eukaryotic translation initiation factor 4 gamma 1
      Short name=eIF-4-gamma 1
      Short name=eIF-4G 1
      Short name=eIF-4G1
Alternative name(s):
    p220
Gene names
Name: EIF4G1
Synonyms: EIF4F, EIF4G, EIF4GI
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1600 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome.

Subunit structure

eIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. Interacts with eIF3, mutually exclusive with EIF4A1 or EIFA2, EIF4E and through its N-terminus with PAPBC1. Interacts through its C-terminus with the serine/threonine kinases MKNK1, and with MKNK2. Appears to act as a scaffold protein, holding these enzymes in place to phosphorylate EIF4E. Non-phosphorylated EIF4EBP1 competes with EIF4G1/EIF4G3 to interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. EIF4G1/EIF4G3 interacts with PABPC1 to bring about circularization of the mRNA. During rotaviral infection, rotavirus RNA-binding protein NSP3 interacts with EIF4G1 and takes the place of PABPC1. Rapamycin can attenuate insulin stimulation mediated by FKBPs. Interacts with EIF4E3. Interacts with MIF4GD.

Post-translational modification

Phosphorylated at multiple sites in vivo.

Following infection by certain enteroviruses, rhinoviruses and aphthoviruses, EIF4G1 is cleaved by the viral protease 2A, or the leader protease in the case of aphthoviruses. This shuts down the capped cellular mRNA transcription.

Sequence similarities

Belongs to the eIF4G family.

Contains 1 MI domain.

Contains 1 MIF4G domain.

Contains 1 W2 domain.

Sequence caution

The sequence BAA02185.1 differs from that shown. Reason: Frameshift at several positions.

Alternative products

This entry describes 6 isoforms produced by alternative splicing and alternative initiation. [Align] [Select]
Isoform 1 (identifier: Q04637-1)

Also known as: A;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q04637-2)

The sequence of this isoform differs from the canonical sequence as follows:
     77-1225: Missing.
Notes: No experimental confirmation available.
Isoform B (identifier: Q04637-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-40: Missing.
Notes: Produced by alternative initiation at Met-41 of isoform 1.
Isoform C (identifier: Q04637-4)

The sequence of this isoform differs from the canonical sequence as follows:
     1-87: Missing.
Notes: Produced by alternative initiation at Met-88 of isoform 1.
Isoform D (identifier: Q04637-5)

The sequence of this isoform differs from the canonical sequence as follows:
     1-164: Missing.
Notes: Produced by alternative initiation at Met-165 of isoform 1.
Isoform E (identifier: Q04637-6)

The sequence of this isoform differs from the canonical sequence as follows:
     1-196: Missing.
Notes: Produced by alternative initiation at Met-197 of isoform 1.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 16001600Eukaryotic translation initiation factor 4 gamma 1
PRO_0000007786

Regions

Domain565 – 792228MIF4G
Domain1242 – 1364123MI
Domain1434 – 1600167W2
Region172 – 20029PABPC1-binding
Region607 – 61812EIF4E-binding
Region682 – 1086405eIF3/EIF4A-binding
Region1451 – 1600150EIF4A-binding
Region1586 – 160015Necessary but not sufficient for MKNK1-binding
Compositional bias454 – 46714Poly-Glu
Compositional bias501 – 5044Poly-Ala

Sites

Site674 – 6752Cleavage; by foot-and-mouth disease virus leader protease
Site681 – 6822Cleavage; by enterovirus/rhinovirus protease 2A

Amino acid modifications

Modified residue2051Phosphothreonine
Modified residue2071Phosphothreonine
Modified residue2231Phosphothreonine
Modified residue5941Phosphotyrosine
Modified residue6471Phosphothreonine
Modified residue10931Phosphoserine
Modified residue11461Phosphoserine
Modified residue11481Phosphoserine
Modified residue11861Phosphoserine
Modified residue11881Phosphoserine
Modified residue12101Phosphoserine
Modified residue12321Phosphoserine
Modified residue15971Phosphoserine

Natural variations

Alternative sequence1 – 196196Missing in isoform E.
VSP_018723
Alternative sequence1 – 164164Missing in isoform D.
VSP_018722
Alternative sequence1 – 8787Missing in isoform C.
VSP_018721
Alternative sequence1 – 4040Missing in isoform B.
VSP_018720
Alternative sequence77 – 12251149Missing in isoform 2.
VSP_013973
Natural variant6961P → L in a colorectal cancer sample; somatic mutation.
VAR_036117

Experimental info

Mutagenesis174 – 1785KRERK → AAAAA: Loss of PABPC1 binding; when associated with 184-AAAA-187
Mutagenesis1801I → A: Loss of PABPC1 binding
Mutagenesis1821I → A: Loss of PABPC1 binding
Mutagenesis184 – 1874DPNQ → AAAA: Loss of PABPC1 binding; when associated with 174-AAAAA-178
Mutagenesis1921I → A: Loss of PABPC1 binding
Mutagenesis1961I → A: Loss of PABPC1 binding
Mutagenesis6121Y → A or F: Abolishes binding to EIF4E
Mutagenesis617 – 6182LL → AA: Abolishes binding to EIF4E
Mutagenesis6821G → A, V, W, R or E: Reduced cleavage by protease 2A from human rhinovirus 2
Mutagenesis7691L → A: Abolishes binding to EIF4A; when associated with A-772 and A-777
Mutagenesis7721L → A: Abolishes binding to EIF4A; when associated with A-769 and A-777
Mutagenesis7771F → A: Abolishes binding to EIF4A; when associated with A-769 and A-772
Mutagenesis843 – 8442LL → AA: Abolishes binding to EIF4A; when associated with A-852 and K-853
Mutagenesis852 – 8532FE → AK: Abolishes binding to EIF4A; when associated with A-843 and A-844
Mutagenesis8971L → A: Abolishes binding to EIF4A; when associated with A-903 and A-906
Mutagenesis9031I → A: Abolishes binding to EIF4A; when associated with A-897 and A-906
Mutagenesis9061L → A: Abolishes binding to EIF4A; when associated with A-897 and A-903
Mutagenesis9751R → A: Abolishes binding to EIF4A; when associated with A-978
Mutagenesis9781F → A: Abolishes binding to EIF4A; when associated with A-975
Mutagenesis9861L → A: Slightly reduced binding to EIF4A; when associated with A-991
Mutagenesis9911W → A: Slightly reduced binding to EIF4A; when associated with A-986
Sequence conflict301P → R in AAC78443. Ref.8
Sequence conflict1381L → F in AAC78443. Ref.3 Ref.7 Ref.8
Sequence conflict1491R → Q in AAC78443. Ref.3 Ref.7 Ref.8
Sequence conflict2141G → S in BAA02185. Ref.4
Sequence conflict4321V → M in CAI46013. Ref.7
Sequence conflict4621E → D in BAA02185. Ref.4
Sequence conflict4681A → V in BAA02185. Ref.4
Sequence conflict4741A → G in BAA02185. Ref.4
Sequence conflict4791G → R in BAA02185. Ref.4
Sequence conflict6041P → L in CAI46013. Ref.7
Sequence conflict625 – 6262AS → CQ in BAA02185. Ref.4
Sequence conflict6971Missing Ref.4 Ref.7
Sequence conflict7651V → W in BAA02185. Ref.4
Sequence conflict8791G → E in BAA02185. Ref.4
Sequence conflict8951R → C in BAA02185. Ref.4
Sequence conflict11051K → Q in BAA02185. Ref.4
Sequence conflict11221N → I in BAA02185. Ref.4
Sequence conflict11861S → T in BAA02185. Ref.4
Sequence conflict13851C → Y in CAI46013. Ref.7
Sequence conflict14721Missing in BAA02185. Ref.4

Secondary structure

....................................................... 1600
Helix Strand Turn

Details...